209 related articles for article (PubMed ID: 30985480)
1. Targeted Biopsy Validation of Peripheral Zone Prostate Cancer Characterization With Magnetic Resonance Fingerprinting and Diffusion Mapping.
Panda A; OʼConnor G; Lo WC; Jiang Y; Margevicius S; Schluchter M; Ponsky LE; Gulani V
Invest Radiol; 2019 Aug; 54(8):485-493. PubMed ID: 30985480
[TBL] [Abstract][Full Text] [Related]
2. MR Fingerprinting and ADC Mapping for Characterization of Lesions in the Transition Zone of the Prostate Gland.
Panda A; Obmann VC; Lo WC; Margevicius S; Jiang Y; Schluchter M; Patel IJ; Nakamoto D; Badve C; Griswold MA; Jaeger I; Ponsky LE; Gulani V
Radiology; 2019 Sep; 292(3):685-694. PubMed ID: 31335285
[TBL] [Abstract][Full Text] [Related]
3. Development of a Combined MR Fingerprinting and Diffusion Examination for Prostate Cancer.
Yu AC; Badve C; Ponsky LE; Pahwa S; Dastmalchian S; Rogers M; Jiang Y; Margevicius S; Schluchter M; Tabayoyong W; Abouassaly R; McGivney D; Griswold MA; Gulani V
Radiology; 2017 Jun; 283(3):729-738. PubMed ID: 28187264
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted magnetic resonance imaging in the prostate transition zone: histopathological validation using magnetic resonance-guided biopsy specimens.
Hoeks CM; Vos EK; Bomers JG; Barentsz JO; Hulsbergen-van de Kaa CA; Scheenen TW
Invest Radiol; 2013 Oct; 48(10):693-701. PubMed ID: 23614975
[TBL] [Abstract][Full Text] [Related]
5. [The value of relaxation time quantitative technique from synthetic magnetic resonance imaging in the diagnosis and invasion assessment of prostate cancer].
Song N; Wang T; Zhang D; Wang Z; Zhang SR; Yu J; Cai L; Ma AL; Zhang Q; Chen ZQ
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(15):1093-1099. PubMed ID: 35436808
[No Abstract] [Full Text] [Related]
6. T1 and T2 MR fingerprinting measurements of prostate cancer and prostatitis correlate with deep learning-derived estimates of epithelium, lumen, and stromal composition on corresponding whole mount histopathology.
Shiradkar R; Panda A; Leo P; Janowczyk A; Farre X; Janaki N; Li L; Pahwa S; Mahran A; Buzzy C; Fu P; Elliott R; MacLennan G; Ponsky L; Gulani V; Madabhushi A
Eur Radiol; 2021 Mar; 31(3):1336-1346. PubMed ID: 32876839
[TBL] [Abstract][Full Text] [Related]
7. T2 Mapping in Prostate Cancer.
Mai J; Abubrig M; Lehmann T; Hilbert T; Weiland E; Grimm MO; Teichgräber U; Franiel T
Invest Radiol; 2019 Mar; 54(3):146-152. PubMed ID: 30394962
[TBL] [Abstract][Full Text] [Related]
8. T1 Mapping of the Prostate Using Single-Shot T1FLASH: A Clinical Feasibility Study to Optimize Prostate Cancer Assessment.
Al-Bourini O; Seif Amir Hosseini A; Giganti F; Balz J; Heitz LG; Voit D; Lotz J; Trojan L; Frahm J; Uhlig A; Uhlig J
Invest Radiol; 2023 Jun; 58(6):380-387. PubMed ID: 36729865
[TBL] [Abstract][Full Text] [Related]
9. T2* relaxation time in the detection and assessment of aggressiveness of peripheral zone cancer in comparison with diffusion-weighted imaging.
Wu LM; Zhou B; Lu Q; Suo ST; Liu Q; Hu J; Haccke EM; Chen XX; Xu JR
Clin Radiol; 2016 Apr; 71(4):356-62. PubMed ID: 26823021
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging.
Rosenkrantz AB; Kopec M; Kong X; Melamed J; Dakwar G; Babb JS; Taouli B
J Magn Reson Imaging; 2010 Jun; 31(6):1387-94. PubMed ID: 20512891
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Analysis of Prostate Multiparametric MR Images for Detection of Aggressive Prostate Cancer in the Peripheral Zone: A Multiple Imager Study.
Hoang Dinh A; Melodelima C; Souchon R; Lehaire J; Bratan F; Mège-Lechevallier F; Ruffion A; Crouzet S; Colombel M; Rouvière O
Radiology; 2016 Jul; 280(1):117-27. PubMed ID: 26859255
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance fingerprinting in prostate cancer before and after contrast enhancement.
Lee YS; Choi MH; Lee YJ; Han D; Kim DH
Br J Radiol; 2022 Mar; 95(1131):20210479. PubMed ID: 34415785
[TBL] [Abstract][Full Text] [Related]
14. Multiparametric Magnetic Resonance Imaging of the Prostate: Repeatability of Volume and Apparent Diffusion Coefficient Quantification.
Fedorov A; Vangel MG; Tempany CM; Fennessy FM
Invest Radiol; 2017 Sep; 52(9):538-546. PubMed ID: 28463931
[TBL] [Abstract][Full Text] [Related]
15. Utility of quantitative apparent diffusion coefficient measurements and normalized apparent diffusion coefficient ratios in the diagnosis of clinically significant peripheral zone prostate cancer.
Nguyen TB; Ushinsky A; Yang A; Nguyentat M; Fardin S; Uchio E; Lall C; Lee T; Houshyar R
Br J Radiol; 2018 Jul; 91(1088):20180091. PubMed ID: 29869921
[TBL] [Abstract][Full Text] [Related]
16. T2 mapping for the characterization of prostate lesions.
Hepp T; Kalmbach L; Kolb M; Martirosian P; Hilbert T; Thaiss WM; Notohamiprodjo M; Bedke J; Nikolaou K; Stenzl A; Kruck S; Kaufmann S
World J Urol; 2022 Jun; 40(6):1455-1461. PubMed ID: 35357510
[TBL] [Abstract][Full Text] [Related]
17. Relationship between T2 relaxation and apparent diffusion coefficient in malignant and non-malignant prostate regions and the effect of peripheral zone fractional volume.
Simpkin CJ; Morgan VA; Giles SL; Riches SF; Parker C; deSouza NM
Br J Radiol; 2013 Apr; 86(1024):20120469. PubMed ID: 23426849
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.
Woodfield CA; Tung GA; Grand DJ; Pezzullo JA; Machan JT; Renzulli JF
AJR Am J Roentgenol; 2010 Apr; 194(4):W316-22. PubMed ID: 20308476
[TBL] [Abstract][Full Text] [Related]
19. Nine-year Follow-up for a Study of Diffusion-weighted Magnetic Resonance Imaging in a Prospective Prostate Cancer Active Surveillance Cohort.
Henderson DR; de Souza NM; Thomas K; Riches SF; Morgan VA; Sohaib SA; Dearnaley DP; Parker CC; van As NJ
Eur Urol; 2016 Jun; 69(6):1028-33. PubMed ID: 26482887
[TBL] [Abstract][Full Text] [Related]
20. Prostate MRI: diffusion-weighted imaging at 1.5T correlates better with prostatectomy Gleason Grades than TRUS-guided biopsies in peripheral zone tumours.
Bittencourt LK; Barentsz JO; de Miranda LC; Gasparetto EL
Eur Radiol; 2012 Feb; 22(2):468-75. PubMed ID: 21913058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
